Why Pre-Workout Supplements Fail Third-Party Testing — And How Sports Nutrition Brands Can Stay Ahead

Pre-workout supplements have a testing problem. Not just a safety problem — a testing problem. Brands that rely on a standard COA covering microbials, heavy metals, and a single potency check for caffeine are leaving significant exposure unmanaged. We see it at our lab regularly: products that pass a basic screen but carry real risk on banned substances, undisclosed stimulants, or label accuracy for multiple stacked actives.

The FDA has issued warning letters to dozens of sports nutrition companies over the past several years, with DMAA (1,3-dimethylamylamine) and DMHA (2-aminoisoheptane) at the center of many of them. Both compounds have appeared in finished pre-workout products without label disclosure, and FDA has repeatedly characterized them as ingredients that don’t meet the safety standard for dietary ingredients under DSHEA. Yet formulations containing them — sometimes listed under alternate nomenclature — still reach Amazon and retail shelves.

That’s not just an FDA enforcement problem. It’s an Amazon listing problem, a brand liability problem, and in the worst cases, a consumer safety problem with real consequences.

The Specific Testing Risks That Make Pre-Workouts Different

Most supplement categories carry a reasonably defined testing risk profile: identity and potency for the active ingredient, heavy metals, microbials, and — depending on botanical sourcing — mycotoxins or pesticide residues. Pre-workouts expand that profile considerably, in directions that many labs don’t flag unless you ask for it.

Start with the stimulant adulteration issue. Pre-workout formulas frequently source raw materials from international suppliers, often in China, where quality control documentation tells only part of the story. Stimulant adulteration is a documented and ongoing problem: DMAA, DMHA, synephrine at concentrated doses, BMPEA (β-methylphenethylamine), and hordenine analogues have all been detected in finished pre-workout products at concentrations suggesting intentional inclusion rather than trace contamination. Research published in Drug Testing and Analysis has identified undisclosed stimulants in commercial pre-workout products — compounds that wouldn’t surface on a standard identity test and wouldn’t be flagged by potency testing of declared ingredients alone.

Then there’s label accuracy across stacked formulas. Pre-workouts are uniquely complex on the label side. A single product might claim specific doses for 8 to 12 different actives: caffeine anhydrous, beta-alanine, L-citrulline malate, creatine monohydrate, betaine anhydrous, L-theanine, BCAAs, and more. Under 21 CFR Part 111, manufacturers are required to test and confirm identity and — when label claims include specific amounts — potency for each listed component. Proprietary blends create their own compliance wrinkle: if a brand declares a “700mg proprietary blend,” the total has to be accurate even if individual component amounts aren’t label-stated. That doesn’t make potency testing unnecessary; it means your risk exposure is different, and your panel needs to reflect that.

And heavy metals and microbials are still required — they’re not guaranteed clean in sports nutrition. Creatine monohydrate sourced from lower-tier offshore suppliers has tested at elevated arsenic levels in some lots. Beta-alanine, one of the most common pre-workout ingredients, can carry microbial load when sourced from inadequately controlled manufacturers. The fact that a product is marketed for athletic performance doesn’t reduce its 21 CFR Part 111 obligations. If anything, the combination of many ingredients from multiple suppliers increases the probability that something fails in a given lot.

Building a Testing Panel That Actually Covers Your Exposure

Here’s what a defensible pre-workout testing panel looks like — not a minimum-viable panel, but a defensible one if FDA reviewed your records tomorrow or Amazon rejected your COA next week.

Identity testing for every declared ingredient. For synthetic actives like creatine, caffeine, and beta-alanine, FTIR or HPLC-based identification is standard and fast. For botanical ingredients — Rhodiola rosea extract, ashwagandha, or lion’s mane, for example — validated methods per USP or AOAC are appropriate. In our experience, identity failures in pre-workouts appear most frequently in L-citrulline (sometimes substituted or cut with citrulline malate at ratios different from the label) and in plant-derived adaptogens where species authentication is skipped.

Potency testing via HPLC or LC-MS/MS for any ingredient carrying a specific quantitative claim on your label. If it says “300mg caffeine per serving,” you need a validated method that confirms that number within acceptable variance. FDA’s warning letter history is instructive here: deviations of more than roughly 20% on a stated potency invite scrutiny, and in enforcement context, they support a misbranding determination. We’ve tested retail pre-workouts where caffeine content deviated from the label by more than 40% — both over and under. Both directions carry liability: over-labeled caffeine means consumers may consume less than expected; under-labeled caffeine (or caffeine from undisclosed sources) is the more dangerous scenario.

Banned substance screening via LC-MS/MS. This is the test that most basic testing packages omit, and for sports nutrition brands it’s the one that can end a product’s career on Amazon or expose a brand to USADA complaint if the product is consumed by competitive athletes. A comprehensive stimulant screen should cover WADA-prohibited substances across stimulant, anabolic, and peptide hormone categories. NSF International’s Certified for Sport program — one of the recognized schemes for sports supplements — screens for over 270 prohibited substances. Not every brand needs full NSF certification, but every pre-workout brand should run a targeted LC-MS/MS stimulant screen at minimum, specifically designed to catch DMAA, DMHA, BMPEA, and structurally related compounds.

Heavy metals per USP <232>/<233>: arsenic, cadmium, lead, and mercury by ICP-MS or ICP-OES. For brands selling into California or to California consumers, Proposition 65 matters here. The Prop 65 maximum allowable dose level (MADL) for lead for reproductive toxicity is 0.5 µg/day — considerably more restrictive than some USP-derived acceptable daily exposures. A pre-workout dosed at two scoops daily needs to clear that threshold, not just a standard USP limit.

Microbial testing per USP <61> and <62>: total aerobic microbial count, total yeast and mold, and absence testing for E. coli and Salmonella. For any product containing botanical raw materials, Staphylococcus aureus testing is also appropriate. Finished product microbial testing is not optional under 21 CFR 111 — it’s a GMP requirement, not a quality-of-life add-on.

What Amazon Requires for Sports Nutrition — and Why a Generic COA Falls Short

Amazon’s supplement compliance program has tightened considerably over the past 18 months. For sports nutrition products, Amazon requires COAs from ISO 17025 accredited laboratories. That requirement isn’t new, but what has changed is how Amazon’s compliance reviewers assess the content of those COAs.

A COA that says “tested per GMP standards” with no listed methods and no accreditation number doesn’t hold up anymore. For sports nutrition products, Amazon’s review process looks for:

• The accreditation body and certificate number (A2LA, Perry Johnson Laboratories, or equivalent ILAC member body)
• Specific, named test methods cited for each parameter (e.g., USP <232> for elemental impurities, AOAC 2012.11 or equivalent for microbials)
• Numerical results with units and stated acceptance limits
• Clear lot number and product identification linking the COA to the specific production run
• Lab signature and stamp from a responsible party at an ISO 17025 accredited facility

Products that include stimulant-adjacent ingredients — high-dose synephrine, yohimbine, anything historically associated with geranium extract — should expect heightened review. Amazon’s compliance team has access to FDA warning letter databases and cross-references ingredient panels against known enforcement targets. It’s not a perfect system, but it catches a meaningful percentage of problematic products. The brands that get reinstated quickly after a compliance review are the ones who already have comprehensive, well-documented COAs in hand before the question gets asked.

There’s also a shelf life dimension to Amazon’s requirements that many brands miss. Amazon can request updated COAs for products that have been listed for 12 or more months without refreshed testing documentation. Planning for annual re-testing of your top SKUs isn’t just a best practice — it’s operational insurance against a mid-year compliance flag on a product that’s already generating revenue.

Getting Your Testing Right Before the First Unit Ships

Sports nutrition brands consistently underestimate testing lead times, and it costs them launch windows. For a pre-workout with 8 to 12 active ingredients requiring identity and potency confirmation for each, plus a banned substance screen and full microbial and metals panel, turnaround from an ISO 17025 lab realistically runs 10 to 15 business days. Add time for any out-of-spec results requiring retest, formula adjustments, or retesting of corrected lots, and you’re potentially looking at 4 to 6 weeks from sample submission to final COA.

Formula changes restart the clock entirely. If your contract manufacturer switches suppliers for creatine or caffeine — even if the declared ingredient stays identical — your existing COA doesn’t cover the new lot. Under 21 CFR 111.75, you’re required to test each received component lot, or alternatively rely on supplier COAs validated through periodic skip-lot testing. The second option has real requirements: you can’t simply accept a supplier COA without documented evidence that the supplier’s testing is reliable. That means your own lab has periodically confirmed the supplier’s results are accurate. Most smaller brands don’t have that documentation, which means full lot-by-lot testing is the compliant path by default.

The brands that handle this operationally well treat testing as part of the procurement and production cycle, not a launch checklist item. They know their lab’s standard turnaround times. They build testing costs into their COGS from the start. They have a standing relationship with an accredited lab that can turn around rush samples when a production schedule doesn’t flex.

Pre-workouts are genuinely high-risk supplements to manufacture and sell. The upside of that — from a market perspective — is real: sports nutrition in the US is growing at roughly 6 to 9 percent annually depending on the segment, and quality-positioned brands can command meaningful price premiums over commodity products. But that upside requires the risk to be managed systematically. A testing program designed for a basic single-ingredient vitamin capsule won’t protect a multi-stimulant, multi-active formula sold on Amazon and consumed daily by competitive athletes and fitness-focused consumers.

Start with the right panel. Test before you launch. Retest when anything in your supply chain changes. And work with a lab that understands what pre-workout formulas actually require — not one that applies a generic supplement template to a category with genuinely different risk characteristics.

---

Written by Nour Abochama, Vice President of Operations, Qalitex Laboratories. Learn more about our team

Talk to our team about your testing needs. Contact us

Related from our network

• FDA Compliance and Audit Preparation for Supplement Brands — Aurora TIC helps dietary supplement companies navigate 21 CFR requirements, FDA audit readiness, and DSHEA compliance strategy.
• Raw Material Identity and Supplier Qualification Testing — Ayah Labs provides contract testing and COA verification for supplement ingredient suppliers and global raw material sourcing.
• Sports Nutrition Testing for the Canadian Market Under Health Canada — Androxa supports brands seeking Natural Health Product (NHP) approval and GMP compliance for the Canadian regulatory pathway.